Lv4
660 积分 2022-10-26 加入
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
6天前
已完结
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
6天前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
6天前
已完结
Tau in Alzheimer's disease: Shaping the future patient journey
2个月前
已关闭
The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau
2个月前
已完结
A clinical-stage RNAi therapeutic candidate for IPF mediates durable MMP7 silencing in nonhuman primates and human lung tissue
2个月前
已关闭
Toxicologic Pathology Forum: Opinion on Interpretive Challenges for Procedure-Related Effects Associated With Direct Central Nervous System Delivery of Oligonucleotides to Rodents, Dogs, and Nonhuman Primates
2个月前
已完结
A clinical-stage RNAi therapeutic candidate for IPF mediates durable MMP7 silencing in nonhuman primates and human lung tissue
2个月前
已关闭
Bimagrumab: an investigational human monoclonal antibody against activin type II receptors for treating obesity
4个月前
已完结
The Type II Activin Receptors Are Essential for Egg Cylinder Growth, Gastrulation, and Rostral Head Development in Mice
4个月前
已完结
皖公网安备34019202002308
